Overview
Autosomal dominant optic atrophy and congenital deafness (also known as optic atrophy with hearing loss, or Konigsmark syndrome) is a rare genetic disorder characterized by the combination of progressive visual loss due to optic nerve atrophy and sensorineural hearing impairment that is present from birth or early childhood. The condition primarily affects two sensory systems: the visual system, through degeneration of the optic nerve leading to reduced visual acuity, color vision deficits, and visual field loss; and the auditory system, through sensorineural deafness that can range from moderate to severe. The optic atrophy typically manifests as pallor of the optic disc observed on fundoscopic examination, and visual deterioration may be progressive over time. This condition follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene inherited from one affected parent is sufficient to cause the disorder. Each child of an affected individual has a 50% chance of inheriting the condition. The molecular genetic basis of this specific entity remains incompletely characterized, and it should be distinguished from other syndromic forms of optic atrophy such as Wolfram syndrome or the more common Kjer-type autosomal dominant optic atrophy (OPA1-related). There is currently no curative treatment available. Management is supportive and multidisciplinary, involving regular ophthalmologic monitoring, low-vision aids, hearing aids or cochlear implants for hearing rehabilitation, and genetic counseling for affected families.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant optic atrophy and congenital deafness.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant optic atrophy and congenital deafness at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant optic atrophy and congenital deafness.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant optic atrophy and congenital deafness.
Start the conversation →Latest news about Autosomal dominant optic atrophy and congenital deafness
No recent news articles for Autosomal dominant optic atrophy and congenital deafness.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal dominant optic atrophy and congenital deafness
What is Autosomal dominant optic atrophy and congenital deafness?
Autosomal dominant optic atrophy and congenital deafness (also known as optic atrophy with hearing loss, or Konigsmark syndrome) is a rare genetic disorder characterized by the combination of progressive visual loss due to optic nerve atrophy and sensorineural hearing impairment that is present from birth or early childhood. The condition primarily affects two sensory systems: the visual system, through degeneration of the optic nerve leading to reduced visual acuity, color vision deficits, and visual field loss; and the auditory system, through sensorineural deafness that can range from moder
How is Autosomal dominant optic atrophy and congenital deafness inherited?
Autosomal dominant optic atrophy and congenital deafness follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal dominant optic atrophy and congenital deafness typically begin?
Typical onset of Autosomal dominant optic atrophy and congenital deafness is childhood. Age of onset can vary across affected individuals.
Which specialists treat Autosomal dominant optic atrophy and congenital deafness?
1 specialists and care centers treating Autosomal dominant optic atrophy and congenital deafness are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.